Legal Guide

Is Compounded Semaglutide Legal?

A provider's guide to the legal status of compounded semaglutide — FDA shortage rules, 503A regulations, and what you need to know to prescribe legally.

Get Provider Access

Open an account in 48 hours

Submitting this form does not create a provider relationship. We'll verify your credentials and follow up within 24 hrs. By submitting, you agree to our Privacy Policy.

Yes — compounded semaglutide is legal when prescribed by a licensed provider and compounded by a licensed pharmacy under specific regulatory conditions. Here's what providers need to know.

When Can Semaglutide Be Compounded?

Under the Federal Food, Drug, and Cosmetic Act, compounding of commercially available drugs is permitted when those drugs are on the FDA Drug Shortage List. Semaglutide has been on the shortage list, allowing licensed compounding pharmacies to prepare compounded versions for individual patients.

Additionally, compounding is permitted when a provider determines that a commercially available product does not meet the medical needs of a specific patient — for example, when a different dosage form, concentration, or combination is clinically needed.

503A and 503B Compounding Rules

The regulatory framework differs by pharmacy type:

  • 503A pharmacies (like Promise Pharmacy) compound semaglutide based on individual patient prescriptions under state regulation
  • 503B outsourcing facilities can produce semaglutide in bulk quantities under FDA oversight

For a detailed comparison: 503A vs 503B Compounding Pharmacy Guide

What Providers Need to Prescribe

  • Valid medical license (MD, DO, NP, PA)
  • Patient-provider relationship (in-person or telehealth where permitted)
  • Individual patient prescription — not "office stock" under 503A
  • A licensed compounding pharmacy partner

Quality and Safety Considerations

When choosing a compounding pharmacy for semaglutide, providers should verify:

  • State licensure and USP compliance (795/797/800)
  • Third-party potency testing — not just in-house testing
  • Sterility and endotoxin testing for injectable compounds
  • Certificate of Analysis availability
  • Proper cold chain shipping procedures

Promise Pharmacy meets all of these standards as a licensed 503A compounding pharmacy.

Staying Current

GLP-1 compounding regulations are evolving. FDA shortage list status, state-level pharmacy rules, and federal compounding guidance can change. Promise Pharmacy monitors regulatory changes and communicates updates to provider partners proactively.

Related

Related Reading

01

503A vs 503B Guide

Understand the two compounding pharmacy models.

Read
02

GLP-1 Shortage Updates

Current semaglutide and tirzepatide shortage status.

Read
03

GLP-1 Program

Our semaglutide and tirzepatide program for providers.

Explore

Get Started

Order Compounded Semaglutide

Licensed 503A semaglutide with third-party testing, wholesale pricing, and 5-day fulfillment.

Open Provider Account